Abstract:It has been unclear whether alteration in DNA methylation at cytokine genes during T helper (Th) cell differentiation is a cause or consequence of gene expression. In this issue of Immunity, Ichiyama et al., 2015Ichiyama K. Chen T. Wang X. Yan X. Kim B.S. Tanaka S. Ndiaye-Lobry D. Deng Y. Zou Y. Zheng P. et al.Immunity. 2015; 42 (this issue): 613-626Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar show that oxidation of 5-methylcytosine by the methylcytosine dioxygenase Tet2 regulates cytokine production in Th cells. It has been unclear whether alteration in DNA methylation at cytokine genes during T helper (Th) cell differentiation is a cause or consequence of gene expression. In this issue of Immunity, Ichiyama et al., 2015Ichiyama K. Chen T. Wang X. Yan X. Kim B.S. Tanaka S. Ndiaye-Lobry D. Deng Y. Zou Y. Zheng P. et al.Immunity. 2015; 42 (this issue): 613-626Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar show that oxidation of 5-methylcytosine by the methylcytosine dioxygenase Tet2 regulates cytokine production in Th cells. Cell-fate determination, including T helper (Th) cell differentiation from naive CD4+ T cells, is often accompanied by the induction of lineage-specifying transcription factors and epigenetic changes at the lineage-specific gene loci (Kanno et al., 2012Kanno Y. Vahedi G. Hirahara K. Singleton K. O’Shea J.J. Annu. Rev. Immunol. 2012; 30: 707-731Crossref PubMed Scopus (262) Google Scholar, Zhu et al., 2010Zhu J. Yamane H. Paul W.E. Annu. Rev. Immunol. 2010; 28: 445-489Crossref PubMed Scopus (2272) Google Scholar). T-bet, GATA-3, RORγt, and Foxp3 are the key transcription factors in determining the fate of Th1, Th2, Th17, and inducible regulatory T (iTreg) cells, respectively. Besides a direct role in transcriptional activation and/or repression, these key transcription factors might also induce specific epigenetic changes at cytokine gene loci, which include modifications to the DNA and associated histones (Wilson et al., 2009Wilson C.B. Rowell E. Sekimata M. Nature Reviews. 2009; 9: 91-105Google Scholar). Genome-wide mapping of the histone modifications in CD4+ T lineages indicates that permissive (H3K4me3) and suppressive (H3K27me3) modifications at the signature cytokine loci are associated with the activation or silencing of these genes, respectively, in specific lineages (Wei et al., 2009Wei G. Wei L. Zhu J. Zang C. Hu-Li J. Yao Z. Cui K. Kanno Y. Roh T.Y. Watford W.T. et al.Immunity. 2009; 30: 155-167Abstract Full Text Full Text PDF PubMed Scopus (893) Google Scholar). In addition, changes in DNA methylation at cytokine gene loci are observed when cells gain the capacity to produce these cytokines during Th cell differentiation (Ansel et al., 2006Ansel K.M. Djuretic I. Tanasa B. Rao A. Annu. Rev. Immunol. 2006; 24: 607-656Crossref PubMed Scopus (532) Google Scholar). However, to date there is little direct evidence to suggest that DNA demethylation is necessary for induction of cytokine gene expression under physiologic conditions. DNA methylation predominately occurs at the 5-position of cytosine (5-methylcytosine, 5mC) within CpG dinucleotides. 5mC pattern is inheritable during DNA duplication and actively maintained by DNA methyltransferases (Dnmts) (Koh and Rao, 2013Koh K.P. Rao A. Curr. Opin. Cell Biol. 2013; 25: 152-161Crossref PubMed Scopus (68) Google Scholar). Hypermethylation in promoter and/or enhancer regions is associated with heterochromatin and/or silenced genes. Oxidation of 5mC by ten-eleven translocation (Tet) family proteins results in production of 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and then 5-carboxylcytosine (5caC). The methyl group is finally removed by thymine DNA glycosylase (TDG) through excision repair. 5hmC, the first intermediate product during cytosine demethylation, is relatively abundant in the genome and much more stable than 5fC or 5caC, indicating that 5hmC might serve as an important epigenetic mark. The function of 5hmC, particularly in T cells, is poorly understood because the conventional bisulfite method to determine DNA methylation status used in early studies does not distinguish 5mC from 5hmC. In this issue of Immunity, Ichiyama et al. use DNA immunoprecipitation (DIP) with specific antibodies to 5mC and 5hmC followed by high-throughput sequencing (DIP-Seq) to map these two modifications genome-wide in distinct T helper cells that were cultured in vitro (Ichiyama et al., 2015Ichiyama K. Chen T. Wang X. Yan X. Kim B.S. Tanaka S. Ndiaye-Lobry D. Deng Y. Zou Y. Zheng P. et al.Immunity. 2015; 42 (this issue): 613-626Abstract Full Text Full Text PDF PubMed Scopus (222) Google Scholar). Dynamic changes of these two modifications are noted in many lineage-specific gene loci. The global distribution patterns of either modification are similar among various Th subsets, with a slight enrichment of both modifications at gene bodies. Interestingly, 5hmC is more abundant in naive CD4+ T cells than in differentiated T helper cells, which is consistent with another genome-wide profiling of 5hmC distribution in T cells using a different method (Tsagaratou et al., 2014Tsagaratou A. Äijö T. Lio C.W. Yue X. Huang Y. Jacobsen S.E. Lähdesmäki H. Rao A. Proc. Natl. Acad. Sci. USA. 2014; 111: E3306-E3315Crossref PubMed Scopus (116) Google Scholar). Binary marks of both 5mC and 5hmC are present at ∼20% of the 5hmC-occupied regions indicating a potential active DNA demethylation process within these regions during T cell differentiation. Binary marks might exist at a higher frequency if the 5mC DIP-seq were to work more efficiently; many known 5mC marks in T cells from the literature including those located in an intron of Foxp3 gene are not identified by 5mC DIP-Seq and there is inconsistency between 5mC DIP-Seq and 5mC DIP-PCR at certain regions suggesting that 5mC DIP-Seq in this study might not be sensitive enough to detect all the 5mC marks. Nevertheless, the 5hmC marks are more likely to co-localize with H3K4me3 modification than 5mC marks. Therefore, 5hmC marks are enriched in active and/or poised genes. Indeed, many lineage-specific 5hmC marks are identified within the evolutionarily conserved non-coding sequence (CNS) regions of the lineage-specific genes, particularly effector cytokine genes including Ifng and Il17a. By contrast, fewer lineage-specific 5hmC marks are present within the gene loci of key transcription factors, such as Gata3 and Rorc. While 5mC marks are present at the CNS (−6 kb) of the Ifng gene in naive CD4+ T cells and Th17 cells judged by DIP-PCR results, 5hmC marks at this region are only detected in Th1 cells (Figure 1). 5hmC, but not 5mC, is preferential found in the regions with p300 binding, which defines active enhancers. In addition, the binding sites for key transcription factors such as T-bet, RORγt, and STAT proteins substantially overlap with 5hmC, but not 5mC in Th1 and Th17 cells, respectively. Therefore, 5hmC modification occurs at the regulatory DNA elements of lineage-specific genes, many of which serve as active enhancers in distinct Th lineages. Conversion from 5mC to 5hmC is catalyzed by Tet family proteins, Tet1, Tet2, and Tet3 (Koh and Rao, 2013Koh K.P. Rao A. Curr. Opin. Cell Biol. 2013; 25: 152-161Crossref PubMed Scopus (68) Google Scholar). Ichiyama et al. show that although all three Tet proteins are expressed in naive CD4+ T cells, their expression is downregulated during T cell activation, leaving only Tet2 expressed in substantial amounts in various Th lineages. Therefore, Tet2 seems to be a reasonable candidate that is responsible for 5hmC modification in distinct Th lineages. Indeed, Tet2 binding is detected at the CNS (−6 kb) of Ifng and the CNS2 of Il17 locus, where 5hmC marks are present in Th1 and Th17 cells, respectively. The recruitment of Tet2 to these regions and thus 5hmC modification depend on the expression of key transcription factors T-bet or RORγt, respectively. Conditional deletion of the Tet2 gene in T cells with Cd2-Cre affects the generation of cytokine-producing cells. Tet2-deficient cells differentiated into Th1 and Th17 lineages have a substantial reduction of 5hmC content at a genome scale. However, only very few genes, such as Ifng, Il17a, and Il10, are significantly affected. Tet2 deficiency not only results in a reduced 5hmC modification in the DNA regulatory elements in these cytokine genes, it also affects histone modification such as H3K4me3, p300 binding, and key transcription factor binding to these elements, indicating that Tet2 and key transcription factors such as T-bet might regulate each other’s function in inducing cytokine production. Ichiyama et al. further show that Tet2 regulates autoimmune responses in vivo. In an experimental autoimmune encephalomyelitis (EAE) model, Tet2 expression in CD4+ T cells restrains the disease severity possibly through regulating IL-10 expression. However, when IL-10 signaling is blocked, Tet2-deficient mice are more resistant to EAE induction, presumably due to impaired induction of IL-17-IFN-γ-dual-producing T cells. Therefore, Tet2 is important for regulating IFN-γ, IL-17a, and IL-10 production both in vitro and in vivo. This study by Ichiyama et al. sheds light on the importance of Tet2-mediated 5mC oxidation at the regulatory elements of effector cytokine genes and the critical function of such epigenetic change in regulating cytokine expression. There are several interesting issues need to be resolved in the future. Is 5hmC, as an intermediate product, simply a readout for active demethylation process or 5hmC itself is important for gene regulation? Many 5hmC-binding proteins have been identified (Koh and Rao, 2013Koh K.P. Rao A. Curr. Opin. Cell Biol. 2013; 25: 152-161Crossref PubMed Scopus (68) Google Scholar). So far, it is unknown which protein(s) can bind to 5hmC in T cells. MeCP2, one of the 5mC binding proteins, is the major molecule binds to 5hmC in neuronal cells; a disease-causing mutant of MeCP2 lost its ability to bind to 5hmC, but is still able to interact with 5mC (Mellén et al., 2012Mellén M. Ayata P. Dewell S. Kriaucionis S. Heintz N. Cell. 2012; 151: 1417-1430Abstract Full Text Full Text PDF PubMed Scopus (705) Google Scholar). T cell-specific deletion of MeCP2 results in impaired cytokine production by Th1 and Th17 cells, although the mechanism for such defect is interpreted differently in the report (Jiang et al., 2014Jiang S. Li C. McRae G. Lykken E. Sevilla J. Liu S.Q. Wan Y. Li Q.J. Sci. Signal. 2014; 7: ra25Crossref PubMed Scopus (49) Google Scholar). Whether MeCP2 has a direct role on effector cytokine production through sensing a change from 5mC to 5hmC at the cytokine loci requires further investigation. In the future, it is also important to determine the relationship among 5hmC marks, histone modifications and transcription factor binding at the cytokine gene loci. Furthermore, what is the function of 5hmC marks at the hundreds of lineage-specific genes whose expression is not altered but 5hmC marks are reduced in the absence of Tet2? Are these 5hmC marks important for terminal differentiation of distinct lineages and/or memory generation? What are the 5hmC patterns in T effector cells that are generated in vivo? Tet2 deficiency does not completely eliminate 5hmC marks at the cytokine gene loci in Th1 and Th17 cells. Also, Tet2 deletion does not affect IL-17f expression in Th17 cells, but the mechanism for differential regulation of IL-17a and IL-17f by Tet2 is unknown. In addition, Tet2 is dispensable for lineage-specific 5hmC marks at the key gene loci in Th2 and iTreg cells. Consistent with this, Tet2 does not bind to these 5hmC regions in these cells and the expression of the signature genes including IL-4 and Foxp3 is not affected by Tet2 deficiency. Our RNA-Seq data and previous reports suggest that both Tet2 and Tet3 are expressed in T cells (Tsagaratou et al., 2014Tsagaratou A. Äijö T. Lio C.W. Yue X. Huang Y. Jacobsen S.E. Lähdesmäki H. Rao A. Proc. Natl. Acad. Sci. USA. 2014; 111: E3306-E3315Crossref PubMed Scopus (116) Google Scholar). Therefore, Tet3 might play an important role in 5hmC production in Th2 and iTreg cells and also have some contribution to 5hmC modification in Th1 and Th17 cells. The importance of 5mC oxidation in promoting cytokine production might be underestimated by Ichiyama et al. in their study. Experiments using Tet2 and Tet3 doubly deficient cells and/or mice might give the answers to these unsolved important questions. C.Z. and J.Z. are supported by the Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T CellsIchiyama et al.ImmunityApril 7, 2015In BriefTet proteins are methylcytosine dioxygenases that convert methyalated DNA (5mC) to hydroxymethylated DNA (5hmC). Dong and colleagues generate a genome-wide 5hmC map in T helper (Th) cells and demonstrate that Tet2-mediated DNA demethylation plays a crucial role in control of signature cytokine expression in Th cells. Full-Text PDF Open Archive

Abstract:Chapter 3 DNA Methylation in the Pathogenesis of Autoimmunity Xueqing Xu, Xueqing Xu Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorPing Yang, Ping Yang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorZhang Shu, Zhang Shu The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorYun Bai, Yun Bai Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorCong-Yi Wang, Cong-Yi Wang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, GA, USASearch for more papers by this author Xueqing Xu, Xueqing Xu Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorPing Yang, Ping Yang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorZhang Shu, Zhang Shu The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSearch for more papers by this authorYun Bai, Yun Bai Department of Medical Genetics, Third Military Medical University, Chongqing, ChinaSearch for more papers by this authorCong-Yi Wang, Cong-Yi Wang The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, GA, USASearch for more papers by this author Book Editor(s):Weikuan Gu, Weikuan Gu Department of Orthopedic Surgery—Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN, USASearch for more papers by this authorYongjun Wang, Yongjun Wang Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaSearch for more papers by this author First published: 21 March 2011 https://doi.org/10.1002/9780470933947.ch3 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onEmailFacebookTwitterLinkedInRedditWechat Summary This chapter contains sections titled: Introduction General Information for DNA Methylation in Mammals DNA Methyltransferases and Methyl-CpG-Binding Domain (MBD) Proteins DNA Methylation in T and B Cell Development The Implication of DNA Methylation in Autoimmune Diseases Common Technological Approaches for Assay of DNA Methylation Summary Acknowledgments References REFERENCES Aggarwal BB, Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397–421. 10.1016/j.bcp.2006.02.009 CASPubMedWeb of Science®Google Scholar Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G. (1998). Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187: 461–68. 10.1084/jem.187.4.461 CASPubMedWeb of Science®Google Scholar Amaravadi L, Klemsz MJ. (1999). DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol 18: 875–84. 10.1089/104454999314737 CASPubMedWeb of Science®Google Scholar Amir RE, Van DV, Wan M, Tran CQ, Francke U, Zoghbi HY. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–88. 10.1038/13810 CASPubMedWeb of Science®Google Scholar Andersen AA, Panning B. (2003). Epigenetic gene regulation by noncoding RNAs. Curr Opin Cell Biol 15: 281–89. 10.1016/S0955-0674(03)00041-3 CASPubMedWeb of Science®Google Scholar Ariel M. (2001). A PCR-based method for studying DNA methylation. Methods Mol Biol 181: 205–16. CASPubMedGoogle Scholar Atkinson MA. (2005). ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54: 1253–63. 10.2337/diabetes.54.5.1253 CASPubMedWeb of Science®Google Scholar Ballestar E, Esteller M, Richardson BC. (2006). The epigenetic face of systemic lupus erythematosus. J Immunol 176: 7143–47. 10.4049/jimmunol.176.12.7143 CASPubMedWeb of Science®Google Scholar Ballestar E, Pile LA, Wassarman DA, Wolffe AP, Wade PA. (2001). A Drosophila MBD family member is a transcriptional corepressor associated with specific genes. Eur J Biochem 268: 5397–406. 10.1046/j.0014-2956.2001.02480.x CASPubMedWeb of Science®Google Scholar Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, Turbachova I, Hamann A, Olek S, Huehn J. (2007). DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated Foxp3(+) conventional T cells. Eur J Immunol 37: 2378–89. 10.1002/eji.200737594 CASPubMedWeb of Science®Google Scholar Bestor TH, Ingram VM. (1983). Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc Natl Acad Sci U S A 80: 5559–63. 10.1073/pnas.80.18.5559 CASPubMedWeb of Science®Google Scholar Bettini M, Vignali DA. (2009). Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21: 612–18. 10.1016/j.coi.2009.09.011 CASPubMedWeb of Science®Google Scholar Bird AP, Wolffe AP. (1999). Methylation-induced repression — belts, braces, and chromatin. Cell 99: 451–54. 10.1016/S0092-8674(00)81532-9 CASPubMedWeb of Science®Google Scholar Bix M, Locksley RM. (1998). Independent and epigenetic regulation of the interleukin-4 alleles in CD4 + T cells. Science 281: 1352–54. 10.1126/science.281.5381.1352 CASPubMedWeb of Science®Google Scholar Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51–58. 10.1016/j.toxlet.2004.01.003 CASPubMedWeb of Science®Google Scholar Bowen H, Kelly A, Lee T, Lavender P. (2008). Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 38: 1422–31. 10.1111/j.1365-2222.2008.03067.x CASPubMedWeb of Science®Google Scholar Brenner C, Fuks F. (2006). DNA methyltransferases: facts, clues, mysteries. Curr Top Microbiol Immunol 301: 45–66. 10.1007/3-540-31390-7_3 CASPubMedWeb of Science®Google Scholar Bruniquel D, Schwartz RH. (2003). Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4: 235–40. 10.1038/ni887 CASPubMedWeb of Science®Google Scholar Callinan PA, Feinberg AP. (2006). The emerging science of epigenomics. Hum Mol Genet 15 (Spec. no 1): R95–101. 10.1093/hmg/ddl095 CASPubMedWeb of Science®Google Scholar Chappell C, Beard C, Altman J, Jaenisch R, Jacob J. (2006). DNA methylation by DNA methyltransferase 1 is critical for effector CD8 T cell expansion. J Immunol 176: 4562–72. 10.4049/jimmunol.176.8.4562 CASPubMedWeb of Science®Google Scholar Cheng LC, Tavazoie M, Doetsch F. (2005). Stem cells: from epigenetics to microRNAs. Neuron 46: 363–67. 10.1016/j.neuron.2005.04.027 CASPubMedWeb of Science®Google Scholar Dahlquist G. (1998). The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 425: 5–10. 10.1111/j.1651-2227.1998.tb01244.x CASPubMedWeb of Science®Google Scholar Danbara M, Kameyama K, Higashihara M, Takagaki Y. (2002). DNA methylation dominates transcriptional silencing of PAX5 in terminally differentiated B cell lines. Mol Immunol 38: 1161–66. 10.1016/S0161-5890(02)00003-2 CASPubMedWeb of Science®Google Scholar Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B. (2003). Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 48: 746–56. 10.1002/art.10833 CASPubMedWeb of Science®Google Scholar Dennis C. (2003). Epigenetics and disease: altered states. Nature 421: 686–88. 10.1038/421686a CASPubMedWeb of Science®Google Scholar Dolinoy DC, Weidman JR, Jirtle RL. (2006). Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23: 297–307. 10.1016/j.reprotox.2006.08.012 CASPubMedWeb of Science®Google Scholar Dubroff LM, Reid RJ Jr. (1980). Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus. Science 208: 404–06. 10.1126/science.7367866 CASPubMedWeb of Science®Google Scholar Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32. 10.1002/jcb.10464 CASPubMedWeb of Science®Google Scholar Egger G, Liang G, Aparicio A, Jones PA. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457–63. 10.1038/nature02625 CASPubMedWeb of Science®Google Scholar Ehrlich M, Jackson K, Weemaes C. (2006). Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 1: 2. 10.1186/1750-1172-1-2 PubMedWeb of Science®Google Scholar Eisenstein EM, Williams CB. (2009). The T(reg)/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res 65: 26R–31R. 10.1203/PDR.0b013e31819e76c7 CASPubMedWeb of Science®Google Scholar Eivazova ER, Aune TM. (2004). Dynamic alterations in the conformation of the IFNγgene region during T helper cell differentiation. Proc Natl Acad Sci U S A 101: 251–56. 10.1073/pnas.0303919101 CASPubMedWeb of Science®Google Scholar Esteller M. (2006). The necessity of a human epigenome project. Carcinogenesis 27: 1121–25. 10.1093/carcin/bgl033 CASPubMedWeb of Science®Google Scholar Fatemi M, Hermann A, Gowher H, Jeltsch A. (2002). DNMT3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 269: 4981–84. 10.1046/j.1432-1033.2002.03198.x CASPubMedWeb of Science®Google Scholar Fatemi M, Wade PA. (2006). MBD family proteins: reading the epigenetic code. J Cell Sci 119: 3033–37. 10.1242/jcs.03099 CASPubMedWeb of Science®Google Scholar Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA. (2004). Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21: 865–76. 10.1016/j.immuni.2004.10.015 CASPubMedWeb of Science®Google Scholar Filippi CM, von Herrath MG. (2008). Viral trigger for type 1 diabetes: pros and cons. Diabetes 57: 2863–71. 10.2337/db07-1023 CASPubMedWeb of Science®Google Scholar Fischle W, Wang Y, Allis CD. (2003). Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172–83. 10.1016/S0955-0674(03)00013-9 CASPubMedWeb of Science®Google Scholar Fitzpatrick DR, Shirley KM, Kelso A. (1999). Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8 + T lymphocytes. J Immunol 162: 5053–57. CASPubMedWeb of Science®Google Scholar Fitzpatrick DR, Wilson CB. (2003). Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 109: 37–45. 10.1016/S1521-6616(03)00205-5 CASPubMedWeb of Science®Google Scholar Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J. (2007). Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol 5: e38. 10.1371/journal.pbio.0050038 CASPubMedWeb of Science®Google Scholar Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. (1991). Light-directed, spatially addressable parallel chemical synthesis. Science 251: 767–73. 10.1126/science.1990438 CASPubMedWeb of Science®Google Scholar Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. (2003). The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31: 1765–74. 10.1093/nar/gkg249 CASPubMedWeb of Science®Google Scholar Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604–09. 10.1073/pnas.0500398102 CASPubMedWeb of Science®Google Scholar Frigola J, Ribas M, Risques RA, Peinado MA. (2002). Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res 30: e28. 10.1093/nar/30.7.e28 PubMedWeb of Science®Google Scholar Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827–31. 10.1073/pnas.89.5.1827 CASPubMedWeb of Science®Google Scholar Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS. (2004). TGF-beta induces Foxp3 + T -regulatory cells from CD4 + C. Am J Transplant 4: 1614–27. 10.1111/j.1600-6143.2004.00566.x CASPubMedWeb of Science®Google Scholar Fuks F. (2005). DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15: 490–95. 10.1016/j.gde.2005.08.002 CASPubMedWeb of Science®Google Scholar Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. (2001). Sensitization for death receptor-or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865–77. 10.1038/sj.onc.1204750 CASPubMedWeb of Science®Google Scholar Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog DNMT2. Science 311: 395–98. 10.1126/science.1120976 CASPubMedWeb of Science®Google Scholar Gonzalgo ML, Liang G, Spruck CH III, Zingg JM, Rideout WM III, Jones PA. (1997). Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 57: 594–99. CASPubMedWeb of Science®Google Scholar Gopisetty G, Ramachandran K, Singal R. (2006). DNA methylation and apoptosis. Mol Immunol 43: 1729–40. 10.1016/j.molimm.2005.11.010 CASPubMedWeb of Science®Google Scholar Goyal R, Reinhardt R, Jeltsch A. (2006). Accuracy of DNA methylation pattern preservation by the DNMT1 methyltransferase. Nucleic Acids Res 34: 1182–88. 10.1093/nar/gkl002 CASPubMedWeb of Science®Google Scholar Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. (2001). Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14: 205–15. 10.1016/S1074-7613(01)00103-0 CASPubMedWeb of Science®Google Scholar Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM. (1999). The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A 96: 14412–17. 10.1073/pnas.96.25.14412 CASPubMedWeb of Science®Google Scholar Hatton RD, Harrington LE, Luther RJ, Wakefield T, Janowski KM, Oliver JR, Lallone RL, Murphy KM, Weaver CT. (2006). A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25: 717–29. 10.1016/j.immuni.2006.09.007 CASPubMedWeb of Science®Google Scholar Hayashi H, Nagae G, Tsutsumi S, Kaneshiro K, Kozaki T, Kaneda A, Sugisaki H, Aburatani H. (2007). High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array. Hum Genet 120: 701–11. 10.1007/s00439-006-0254-6 CASPubMedWeb of Science®Google Scholar Heller G, Zielinski CC, Zochbauer-Muller S. (2010). Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 29 (1): 95–107. 10.1007/s10555-010-9203-x CASPubMedWeb of Science®Google Scholar Hendrich B, Abbott C, McQueen H, Chambers D, Cross S, Bird A. (1999). Genomic structure and chromosomal mapping of the murine and human MBD1, MBD2, MBD3, and MBD4 genes. Mamm Genome 10: 906–12. 10.1007/s003359901112 CASPubMedWeb of Science®Google Scholar Hendrich B, Bird A. (1998). Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538–47. 10.1128/MCB.18.11.6538 CASPubMedWeb of Science®Google Scholar Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. (2001). Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 15: 710–23. 10.1101/gad.194101 CASPubMedWeb of Science®Google Scholar Hendrich B, Tweedie S. (2003). The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19: 269–77. 10.1016/S0168-9525(03)00080-5 CASPubMedWeb of Science®Google Scholar Henikoff S, Furuyama T, Ahmad K. (2004). Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20: 320–26. 10.1016/j.tig.2004.05.004 CASPubMedWeb of Science®Google Scholar Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821–26. 10.1073/pnas.93.18.9821 CASPubMedWeb of Science®Google Scholar Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL. (2001). Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 276: 39508–11. 10.1074/jbc.C100343200 CASPubMedWeb of Science®Google Scholar Hofstetter H, Gold R, Hartung HP. (2009). Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 16: 12–18. PubMedGoogle Scholar Holliday R. (2006). Dual inheritance. Curr Top Microbiol Immunol 301: 243–56. 10.1007/3-540-31390-7_9 CASPubMedWeb of Science®Google Scholar Hutchins AS, Artis D, Hendrich BD, Bird AP, Scott P, Reiner SL. (2005). Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol 175: 5606–10. 10.4049/jimmunol.175.9.5606 CASPubMedWeb of Science®Google Scholar Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, Bird AP, Reiner SL. (2002). Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 10: 81–91. 10.1016/S1097-2765(02)00564-6 CASPubMedWeb of Science®Google Scholar Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126: 1121–33. 10.1016/j.cell.2006.07.035 CASPubMedWeb of Science®Google Scholar Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O. (2008). Foxp3 promoter demethylation reveals the committed Treg population in humans. PLoS One 3: e1612. 10.1371/journal.pone.0001612 CASPubMedWeb of Science®Google Scholar Jeltsch A, Walter J, Reinhardt R, Platzer M. (2006). German human methylome project started. Cancer Res 66: 73–78. 10.1158/0008-5472.CAN-06-1071 Web of Science®Google Scholar Jones B, Chen J. (2006). Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 25: 2443–52. 10.1038/sj.emboj.7601148 CASPubMedWeb of Science®Google Scholar Jones PA, Martienssen R. (2005). A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 65: 11241–46. 10.1158/0008-5472.CAN-05-3865 CASPubMedWeb of Science®Google Scholar Junien C, Gallou-Kabani C, Vige A, Gross MS. (2005). [Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations]. Ann Endocrinol (Paris) 66: 2S19–28. CASPubMedGoogle Scholar Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. (2004). Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4 + lupus T cells. J Immunol 172: 3652–61. 10.4049/jimmunol.172.6.3652 CASPubMedWeb of Science®Google Scholar Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60: 3613–22. 10.1002/art.25018 CASPubMedWeb of Science®Google Scholar Kim HP, Leonard WJ. (2007). CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204: 1543–51. 10.1084/jem.20070109 CASPubMedWeb of Science®Google Scholar Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. (2005). Environmental triggers and determinants of type 1 diabetes. Diabetes 54 (Suppl 2): S125–36. 10.2337/diabetes.54.suppl_2.S125 CASPubMedWeb of Science®Google Scholar Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. (2009). Heterogeneity of natural Foxp3 + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 106: 1903–08. 10.1073/pnas.0811556106 CASPubMedWeb of Science®Google Scholar Korb A, Pavenstadt H, Pap T. (2009). Cell death in rheumatoid arthritis. Apoptosis 14: 447–54. 10.1007/s10495-009-0317-y PubMedWeb of Science®Google Scholar Koturbash I, Baker M, Loree J, Kutanzi K, Hudson D, Pogribny I, Sedelnikova O, Bonner W, Kovalchuk O. (2006a). Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. Int J Radiat Oncol Biol Phys 66: 327–30. 10.1016/j.ijrobp.2006.06.012 CASPubMedWeb of Science®Google Scholar Koturbash I, Rugo RE, Hendricks CA, Loree J, Thibault B, Kutanzi K, Pogribny I, Yanch JC, Engelward BP, Kovalchuk O. (2006b). Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene 25: 4267–75. 10.1038/sj.onc.1209467 CASPubMedWeb of Science®Google Scholar Kouskouti A, Talianidis I. (2005). Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24: 347–57. 10.1038/sj.emboj.7600516 CASPubMedWeb of Science®Google Scholar Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, Reid SP, Levy DE, Bromberg JS. (2009). Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 182: 259–73. 10.4049/jimmunol.182.1.259 CASPubMedWeb of Science®Google Scholar Lee BH, Yegnasubramanian S, Lin X, Nelson WG. (2005). Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 280: 40749–56. 10.1074/jbc.M505593200 CASPubMedWeb of Science®Google Scholar Lee DU, Agarwal S, Rao A. (2002). Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16: 649–60. 10.1016/S1074-7613(02)00314-X CASPubMedWeb of Science®Google Scholar Leonhardt H, Page AW, Weier HU, Bestor TH. (1992). A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865–73. 10.1016/0092-8674(92)90561-P CASPubMedWeb of Science®Google Scholar Li HP, Leu YW, Chang YS. (2005a). Epigenetic changes in virus-associated human cancers. Cell Res 15: 262–71. 10.1038/sj.cr.7290295 CASPubMedWeb of Science®Google Scholar Li JZ, Steinman CR. (1989). Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum 32: 726–33. 10.1002/anr.1780320610 CASPubMedWeb of Science®Google Scholar Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY. (2005b). Sumo wrestling with type 1 diabetes. J Mol Med 83: 504–13. 10.1007/s00109-005-0645-5 CASPubMedWeb of Science®Google Scholar Liu L, Wylie RC, Andrews LG, Tollefsbol TO. (2003). Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124: 989–98. 10.1016/j.mad.2003.08.001 CASPubMedWeb of Science®Google Scholar Luo X, Zhang Q, Liu V, Xia Z, Pothoven KL, Lee C. (2008). Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J Immunol 180: 2757–61. 10.4049/jimmunol.180.5.2757 CASPubMedWeb of Science®Google Scholar Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. (2006). High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989–95. 10.1158/1078-0432.CCR-05-2096 CASPubMedWeb of Science®Google Scholar Maier H, Colbert J, Fitzsimmons D, Clark DR, Hagman J. (2003). Activation of the early B-cell-specific MB-1 (IG-alpha) gene by Pax-5 is dependent on an unmethylated ETS binding site. Mol Cell Biol 23: 1946–60. 10.1128/MCB.23.6.1946-1960.2003 CASPubMedWeb of Science®Google Scholar Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. (2003). Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4: 1183–90. 10.1038/ni1004 CASPubMedWeb of Science®Google Scholar Makar KW, Wilson CB. (2004). DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402–06. 10.4049/jimmunol.173.7.4402 CASPubMedWeb of Science®Google Scholar Mattick JS. (2001). Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2: 986–91. 10.1093/embo-reports/kve230 CASPubMedWeb of Science®Google Scholar Mazari L, Ouarzane M, Zouali M. (2007). Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A 104: 6317–22. 10.1073/pnas.0610434104 CASPubMedWeb of Science®Google Scholar Meaney MJ, Szyf M. (2005). Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7: 103–23. 10.31887/DCNS.2005.7.2/mmeaney PubMedGoogle Scholar Meehan RR, Lewis JD, Bird AP. (1992). Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085–92. 10.1093/nar/20.19.5085 CASPubMedWeb of Science®Google Scholar Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD. (2001). Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care 24: 838–42. 10.2337/diacare.24.5.838 CASPubMedWeb of Science®Google Scholar Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A. (2002). Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297: 403–05. 10.1126/science.1073354 CASPubMedWeb of Science®Google Scholar Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. (2009). Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 30: 899–911. 10.1016/j.immuni.2009.03.019 CASPubMedWeb of Science®Google Scholar Moon C, Kim SH, Park KS, Choi BK, Lee HS, Park JB, Choi GS, Kwan JH, Joh JW, Kim SJ. (2009). Use of epigenetic modification to induce Foxp3 expression in naive T cells. Transplant Proc 41: 1848–54. 10.1016/j.transproceed.2009.02.101 CASPubMedWeb of Science®Google Scholar Morgan HD, Sutherland HG, Martin DI, Whitelaw E. (1999). Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23: 314–18. 10.1038/15490 CASPubMedWeb of Science®Google Scholar Natoli G, Saccani S, Bosisio D, Marazzi I. (2005). Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439–45. 10.1038/ni1196 CASPubMedWeb of Science®Google Scholar Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, Gay RE, Gay S. (2000). Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthriti

IL-2 and GM-CSF Are Regulated by DNA Demethylation During Activation of T Cells, B Cells and Macrophages.

Widespread genomic de novo DNA methylation occurs following CD8+ T cell activation and proliferation

The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites

Plasticity of DNA methylation in mouse T cell activation and differentiation

The Proinflammatory Cytokine TNFα Induces DNA Demethylation–dependent and –independent Activation of Interleukin-32 Expression

315.4: CREB May Regulate Gene Expression in MDSC Differentiation by Influencing DNA Methylation

Tet2: Breaking Down Barriers to T Cell Cytokine Expression

KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling

Methyltransferase Dot1l Preferentially Promotes Innate IL-6 and IFN-β Production by Mediating H3K79me2/3 Methylation in Macrophages

Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene.

DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells

DNA demethylation switches the drivers of Foxp3 expression to maintain regulatory T cell identity

Tissue-specific DNA demethylation is required for proper B-cell differentiation and function

DNA Methylation in the Pathogenesis of Autoimmunity

Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells

Molecular Mechanisms of Interleukin-2 Gene Inducibility: Developmental Control and Combinatorial Action of Transcription Factors

Duck IL-2 Promoter Cloning and the Effects of Methylation Status on Mrna Levels in Immune Tissues

Global Mapping of H3K4me3 and H3K27me3 Reveals Chromatin State-Based Regulation of Human Monocyte-Derived Dendritic Cells in Different Environments

Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites

Epigenetic Regulatory Effects of the Methylation of CpG Island Shore on the Expression of Lag3 Gene in Various Human T Cell Lines

Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells.